Pro-inflammatory activated Kupffer cells by lipids induce hepatic NKT cells deficiency through activation-induced cell death

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Tang, Tongfang ^a   Sui, Yongheng ^a   Lian, Min ^a   Li, Zhiping ^b   Hua, Jing ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD1D ANTIGEN; CYTOKINE; FATTY ACID; LIPID; TOLL LIKE RECEPTOR 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTATION; APOPTOSIS; ARTICLE; CELL ACTIVATION; CELL COUNT; CELL DEATH; CELL FUNCTION; CELL SURFACE; COCULTURE; CONTROLLED STUDY; FATTY LIVER; GENE EXPRESSION; IN VITRO STUDY; IN VIVO STUDY; KUPFFER CELL; LIPID DIET; MALE; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; WILD TYPE;

ANIMALS; ANTIGEN PRESENTATION; CELL DEATH; CYTOKINES; DIET, HIGH-FAT; DIETARY FATS; DRUG SYNERGISM; FATTY LIVER; GENE EXPRESSION REGULATION; INFLAMMATION; KUPFFER CELLS; LIPOPOLYSACCHARIDES; LIVER; MACROPHAGE ACTIVATION; MALE; MICE; MICE, INBRED C57BL; NATURAL KILLER T-CELLS; TOLL-LIKE RECEPTOR 4;

EID: 84891667680     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0081949     Document Type: Article

References (42)

1. Lazo M, Clark JM (2008) The epidemiology of nonalcoholic fatty liver disease: a global perspective. Semin Liver Dis 28: 339-350. doi:10.1055/s-0028- 1091978. PubMed: 18956290.
2. de Wit NJ, Afman LA, Mensink M, Müller M (2012) Phenotyping the effect of diet on non-alcoholic fatty liver disease. J Hepatol 57: 1370-1373. doi:10.1016/j.jhep.2012.07.003. PubMed: 22796155.
3. Lalor PF, Faint J, Aarbodem Y, Hubscher SG, Adams DH (2007) The role of cytokines and chemokines in the development of steatohepatitis. Semin Liver Dis 27: 173-193. doi:10.1055/s-2007-979470. PubMed: 17520517.
4. Figler RA, Wang G, Srinivasan S, Jung DY, Zhang Z et al. (2011) Links between insulin resistance, adenosine A2B receptors, and inflammatory markers in mice and humans. Diabetes 60: 669-679. doi:10.2337/db10-1070. PubMed: 21270276.
5. Li Z, Diehl AM (2003) Innate immunity in the liver. Curr Opin Gastroenterol 19: 565-571. doi:10.1097/00001574-200311000-00009. PubMed: 15703606.
6. Maher JJ, Leon P, Ryan JC (2008) Beyond insulin resistance:innate immunity in nonalcoholic steatohepatitis. Hepatology 48: 670-678. doi:10.1002/hep.22399. PubMed: 18666225.
7. Racanelli V, Rehermann B (2006) The liver as an immunological organ. Hepatology 43: S54-S62. doi:10.1002/hep.21060. PubMed: 16447271.
8. Dong Z, Wei H, Sun R, Tian Z (2007) The roles of innate immune cells in liver injury and regeneration. Cell Mol Immunol 4: 241-252. PubMed: 17764614.
9. Dixon LJ, Barnes M, Tang H, Pritchard MT, Nagy LE. (2013) Kupffer Cells in the Liver. Compr Physiol 3:785-797.
10. Diehl AM (2002) Nonalcoholic steatosis and steatohepatitis IV. Nonalcoholic fatty liver disease abnormalities in macrophage function and cytokines. Am J Physiol Gastrointest Liver Physiol 282: G1-G5. PubMed: 11751151.
11. Odegaard JI, Ricardo-Gonzalez RR, Red Eagle A, Vats D, Morel CR et al. (2008) Alternative M2 activation of Kupffer cells by PPARdelta ameliorates obesity-induced insulin resistance. Cell Metab 7: 496-507. doi:10.1016/j.cmet. 2008.04.003. PubMed: 18522831.
12. Huang W, Metlakunta A, Dedousis N, Zhang P, Sipula I et al. (2010) Depletion of liver Kupffer cells prevents the development of diet-induced hepatic steatosis and insulin resistance. Diabetes 59: 347-357. doi:10.2337/db09-0016. PubMed: 19934001.
13. Bendelac A, Savage PB, Teyton L (2007) The biology of NKT cells. Annu Rev Immunol 25: 297-336. doi:10.1146/annurev.immunol.25.022106.141711. PubMed: 17150027.
14. Sköld M, Behar SM (2003) Role of CD1d-restricted NKT cells in microbial immunity. Infect Immun 71: 5447-5455. doi:10.1128/IAI.71.10.5447-5455. 2003. PubMed: 14500461.
15. Simoni Y, Diana J, Ghazarian L, Beaudoin L, Lehuen A (2013) Therapeutic manipulation of natural killer (NK) T cells in autoimmunity: are we close to reality? Clin Exp Immunol 171: 8-19. doi:10.1111/j.1365-2249.2012.04625.x. PubMed: 23199318.
16. Geissmann F, Cameron TO, Sidobre S, Manlongat N, Kronenberg M et al. (2005) Intravascular immune surveillance by CXCR6+ NKT cells patrolling liver sinusoids. PLoS Biol 3: e113. doi:10.1371/journal.pbio.0030113. PubMed: 15799695.
17. Li Z, Soloski MJ, Diehl AM (2005) Dietary factors alter hepatic innate immune system in mice with nonalcoholic fatty liver disease. Hepatology 42: 880-885. doi:10.1002/hep.20826. PubMed: 16175608.
18. Li Z, Oben JA, Yang S, Lin H, Ea et al Bstafford. (2004) Norepinephrine regulates hepatic innate immune system in leptin-deficient mice with nonalcoholic steatohepatitis. Hepatology 40: 434-444. doi:10.1002/hep.20320. PubMed: 15368448.
19. Elinav E, Pappo O, Sklair-Levy M, Margalit M, Shibolet O et al. (2006) Adoptive transfer of regulatory NKT lymphocytes ameliorates nonalcoholic steatohepatitis and glucose intolerance in ob/ob mice and is associated with intrahepatic CD8 trapping. J Pathol 209: 121-128. doi:10.1002/path.1950. PubMed: 16482497.
20. Hua J, Ma X, Webb T, Potter JJ, Oelke M et al. (2010) Dietary fatty acids modulates antigen presentation to hepatic NKT cells in nonalcoholic fatty liver disease. J Lipid Res 51: 1696-1703. doi:10.1194/jlr.M003004. PubMed: 20185414.
21. Trobonjaca Z, Leithäuser F, Möller P, Schirmbeck R, Reimann J (2001) Activating immunity in the liver. I. Liver dendritic cells (but not hepatocytes) are potent activators of IFN-gamma release by liver NKT cells. J Immunol 167: 1413-1422. PubMed: 11466360.
22. Hua J, Qiu, de K, Li JQ, Li EL, Chen XY et al. (2007) Expression of Toll-like receptor 4 in rat liver during the course of carbon tetrachloride-induced liver injury. J Gastroenterol Hepatol 22: 862-869. doi:10.1111/j.1440-1746.2007.04896.x. PubMed: 17504260.
23. Potter JJ, Yang VW, Mezey E (1989) Influence of growth hormone on the synthesis of rat liver alcohol dehydrogenase in primary hepatocyte culture. Arch Biochem Biophys 274: 548-555. doi:10.1016/0003-9861(89)90469-4. PubMed: 2802627.
24. Kremer M, Hines IN, Milton RJ, Wheeler MD (2006) Favored T helper 1 response in a mouse model of hepatosteatosis is associated with enhanced T cell-mediated hepatitis. Hepatology 44: 216-227. doi:10.1002/hep.21221. PubMed: 16799967.
25. Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H et al. (2006) TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 116: 3015-3025. doi:10.1172/JCI28898. PubMed: 17053832.
26. Lee JY, Ye J, Gao Z, Youn HS, Lee WH et al. (2003) Reciprocal modulation of Toll-like receptor-4 signaling pathways involving MyD88 and phosphatidylinositol 3-kinase/AKT by saturated and polyunsaturated fatty acids. J Biol Chem 278: 37041-37051. doi:10.1074/jbc.M305213200. PubMed: 12865424.
27. Rivera CA, Adegboyega P, van Rooijen N, Tagalicud A, Allman M et al. (2007) Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of nonalcoholic steatohepatitis. J Hepatol 47:571e9.
28. Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C et al. (2007) Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56: 1761-1772. doi:10.2337/db06-1491. PubMed: 17456850.
29. Muriel P, Escobar Y (2003) Kupffer cells are responsible for liver cirrhosis induced by carbon tetrachloride. J Appl Toxicol 23: 103-108. doi:10.1002/jat.892. PubMed: 12666154.
30. Hatano M, Sasaki S, Ohata S, Shiratsuchi Y, Yamazaki T et al. (2008) Effects of Kupffer cell-depletion on Concanavalin A-induced hepatitis. Cell Immunol 251: 25-30. doi:10.1016/j.cellimm.2008.02.003. PubMed: 18374909.
31. Baffy G (2009) Kupffer cells in non-alcoholic fatty liver disease: the emerging view. J Hepatol 51: 212-223. doi:10.1016/j.jhep.2009.03.008. PubMed: 19447517.
32. Leroux A, Ferrere G, Godie V, Cailleux F, Renoud ML et al. (2012) Toxic lipids stored by Kupffer cells correlates with their pro-inflammatory phenotype at an early stage of steatohepatitis. J Hepatol 57: 141-149. doi:10.1016/j.jhep.2012.02.028. PubMed: 22425624.
33. Harte AL, da Silva NF, Creely SJ, McGee KC, Billyard T, et al. (2010) Elevated endotoxin levels in non-alcoholic fatty liver disease. J Inflamm (Lond) 30:7-15.
34. Mosser DM, Edwards JP (2008) Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8: 958-969. doi:10.1038/nri2448. PubMed: 19029990.
35. Shono S, Habu Y, Nakashima M, Sato A, Nakashima H et al. (2011) The immunologic outcome of enhanced function of mouse liver lymphocytes and Kupffer cells byhigh-fat and high-cholesterol diet. Shock 36: 484-493. doi:10.1097/SHK.0b013e31822dc6e4. PubMed: 21937954.
36. Nakashima H, Ogawa Y, Shono S, Kinoshita M, Nakashima M et al. (2013) Activation of CD11b+ Kupffer cells/macrophages as a common cause for exacerbation of TNF/Fas-ligand-dependent hepatitis in hypercholesterolemic mice.PLOS ONE 8(1): e49339. doi:10.1371/journal.pone.0049339. PubMed: 23372642.
37. Yang L, Jhaveri R, Huang J, Qi Y, Diehl AM (2007) Endoplasmic reticulum stress, hepatocyte CD1d and NKT cell abnormalities in murine fatty livers. Lab Invest 87: 927-937. doi:10.1038/labinvest.3700603. PubMed: 17607300.
38. Kremer M, Thomas E, Milton RJ, Perry AW, van Rooijen N et al. (2010) Kupffer cell and interleukin-12-dependent loss of natural killer T cells in hepatosteatosis. Hepatology 51: 130-141. doi:10.1002/hep.23292. PubMed: 20034047.
39. Lee WY, Moriarty TJ, Wong CH, Zhou H, Strieter RM, et al. (2010) An intravascular immune response to Borrelia burgdorferi involves Kupffer cells and iNKT cells. Nat Immunol 11:295-302.
40. Ma X, Hua J, Li Z (2008) Probiotic improve high fat diet-induced hepatic steatosis and insulin resistance by increasing hepatic NKT cell. J Hepatol 49: 821-830. doi:10.1016/j.jhep.2008.05.025. PubMed: 18674841.
41. Syn WK, Oo YH, Pereira TA, Karaca GF, Jung Y et al. (2010) Accumulation of natural killer T cells in progressive nonalcoholic fatty liver disease.Hepatology 51: 1998-2007. doi:10.1002/hep.23599. PubMed: 20512988.
42. Tajiri K, Shimizu Y, Tsuneyama K, Sugiyama T (2009) Role of liver-infiltrating CD3+CD56+ natural killer T cells in the pathogenesis of nonalcoholic fatty liver disease. Eur J Gastroenterol Hepatol 21: 673-680. doi:10.1097/MEG.0b013e32831bc3d6. PubMed: 19318971.